Skip to main content
SpringerLink
Log in
Book cover

Multimodal Concepts for Integration of Cytotoxic Drugs pp 267–283Cite as

Applications in Rectal and Anal Cancer

  • Chapter

  • 562 Accesses

Part of the Medical Radiology book series (Med Radiol Radiat Oncol)

Keywords

  • Rectal Cancer
  • Clin Oncol
  • Maximum Tolerate Dose
  • Radiat Oncol Biol Phys
  • Anal Cancer

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allal A, Kurtz JM, Pipard G et al (1993) Radiochemotherapy versus radiotherapy alone for anal cancer: a retrospective comparison. Int J Radiat Oncol Biol Phys 27:59–66

    PubMed  CAS  Google Scholar 

  • Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343–2351

    CrossRef  PubMed  CAS  Google Scholar 

  • Aschele C, Friso ML, Pucciarelli S et al (2005) A phase I–II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 16:1140–1146

    CrossRef  PubMed  CAS  Google Scholar 

  • Bartelink H, Roelofsen F, Eschwege F et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040–2049

    PubMed  CAS  Google Scholar 

  • Baumann M, Krause M (2004) Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results. Radiother Oncol 72:257–266

    CrossRef  PubMed  CAS  Google Scholar 

  • Blackstock AW, Hess S, Chaney S et al (1999) Oxaliplatin: in vitro evidence of its radiation sensitizing activity: preclinical observations relevant to clinical trials. Int J Radiat Oncol Biol Phys 45:253–254

    CrossRef  Google Scholar 

  • Bosset JF, Roelofsen F, Morgan DA et al (2003) Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups. Eur J Cancer 39:45–51

    CrossRef  PubMed  CAS  Google Scholar 

  • Bosset JF, Calais G, Mineur L et al (2005a) Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921. J Clin Oncol 23:5620–5627

    CrossRef  PubMed  CAS  Google Scholar 

  • Bosset JF, Calais G, Mineur L et al (2005b) Preoperative radiation (Preop RT) in rectal cancer: effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial. Proc Am Soc Clin Oncol, Abstract 3505

    Google Scholar 

  • Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2004) Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs conventionally fractionated radiochemotherapy. Radiother Oncol 72:15–24

    CrossRef  PubMed  CAS  Google Scholar 

  • Byfield JE, Calabro-Jones P, Klisak I et al (1982) Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays. Int J Radiat Oncol Biol Phys 8:1923–1933

    PubMed  CAS  Google Scholar 

  • Cafiero F, Gipponi M, Lionetto R (2003) Randomised clinical trial of adjuvant postoperative RT vs sequential postoperative RT plus 5-FU and levamisole in patients with stage II–III resectable rectal cancer: a final report. J Surg Oncol 83:140–146

    CrossRef  PubMed  CAS  Google Scholar 

  • Carraro S, Roca EL, Cartelli C et al (2002) Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3–T4 unresectable rectal cancer: a phase II IATTGI study. Int J Radiat Oncol Biol Phys 54:397–402

    CrossRef  PubMed  CAS  Google Scholar 

  • Cividalli A, Ceciarelli F, Livdi E et al (2002) Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule. Int J Radiat Oncol Biol Phys 52:1092–1098

    CrossRef  PubMed  CAS  Google Scholar 

  • Cummings BJ, Keane TJ, O’Sullivan B et al (1991) Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21:1115–1125

    PubMed  CAS  Google Scholar 

  • Dobrowsky W, Dobrowsky E, Rauth AM (1992) Mode of interaction of 5-fluorouracil, radiation, and mitomycin C: in vitro studies. Int J Radiat Oncol Biol Phys 22:875–880

    PubMed  CAS  Google Scholar 

  • Doci R, Zucali R, La Monica G et al (1996) Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. J Clin Oncol 14:3121–3125

    PubMed  CAS  Google Scholar 

  • Dunst J, Reese T, Sutter T et al (2002) Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 20:3983–3991

    CrossRef  PubMed  CAS  Google Scholar 

  • Eng C, Crane CH, Rosner GL et al (2005) A phase II study of capecitabine plus oxaliplatin and radiation therapy, XELOX-XRT, in squamous cell carcinoma (SCCA) of the anal canal: a preliminary analysis. Proc Am Soc Clin Oncol, Abstract 4271

    Google Scholar 

  • Fernandez-Martos C, Aparicio J, Bosch C et al (2004) Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years’ follow-up. J Clin Oncol 22:3016–3022

    CrossRef  PubMed  CAS  Google Scholar 

  • Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocrinol Rev 18:4–25

    CrossRef  CAS  Google Scholar 

  • Ferrigno R, Nakamura RA, Dos Santos Novaes PE et al (2005) Radiochemotherapy in the conservative treatment of anal carcinoma: retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys 61:1136–1142

    CrossRef  PubMed  Google Scholar 

  • Flam M, John M, Pajak TF et al (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14:2527–2539

    PubMed  CAS  Google Scholar 

  • Freyer G, Bossard N, Romestaing P et al (2001) Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial. J Clin Oncol 19:2433–2438

    PubMed  CAS  Google Scholar 

  • Frykholm GJ, Glimelius B, Pahlman L (1993) Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36:564–572

    CrossRef  PubMed  CAS  Google Scholar 

  • Frykholm GJ, Påhlman L, Glimelius B (2001) Combined chemo-and radiotherapy vs radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 50:427–434

    CrossRef  PubMed  CAS  Google Scholar 

  • Gambacorta MA, Valentini V, Coco C et al (2004) Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II–III resectable rectal cancer: phase I and II studies. Int J Radiat Oncol Biol Phys 60:139–148

    CrossRef  PubMed  CAS  Google Scholar 

  • Gastrointestinal Tumor Study Group (1985) Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 312:1465–1472

    CrossRef  Google Scholar 

  • Gastrointestinal Tumor Study Group (1992) Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 10:549–557

    Google Scholar 

  • Gerard JP, Chapet O, Nemoz C et al (2003) Preoperative concurrent radiochemotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol 21:1119–1124

    CrossRef  PubMed  Google Scholar 

  • Gerard JP, Bonnetain F, Conroy T et al (2005) Preoperative (preop) radiotherapy (RT) + 5 FU/folinic acid (FA) in T3–4 rectal cancers: results of the FFCD 9203 randomized trial. Proc Am Soc Clin Oncol, Abstract 3504

    Google Scholar 

  • Giacchetti S, Itzhaki M, Gruia G et al (1999) Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10:663–669

    CrossRef  PubMed  CAS  Google Scholar 

  • Giacchetti S, Perpoint B, Zidani R et al (2000) Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18:136–147

    PubMed  CAS  Google Scholar 

  • Giralt J, Heras M de las, Cerezo L et al (2005) The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis. Radiother Oncol 74:101–108

    CrossRef  PubMed  CAS  Google Scholar 

  • Grabenbauer GG, Kessler H, Matzel KE et al (2005) Tumor site predicts outcome after radiochemotherapy in squamouscell carcinoma of the anal region: long-term results of 101 patients. Dis Colon Rectum 48:1742–1751

    CrossRef  PubMed  Google Scholar 

  • Heidelberger C, Chaudhuri NK, Danneberg P et al (1957) Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179:663–666

    CrossRef  PubMed  CAS  Google Scholar 

  • Heidelberger C, Griesbach L, Montag BJ et al (1958) Studies on fluorinated pyrimidines. II. Effects on transplanted tumors. Cancer Res 18:305–317

    PubMed  CAS  Google Scholar 

  • Hofheinz RD, Gerstenberg-Helldorf B von, Wenz F et al (2005) Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer. J Clin Oncol 23:1350–1357

    CrossRef  PubMed  CAS  Google Scholar 

  • Kim JC, Kim TW, Kim JH et al (2005) Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 63:346–353

    CrossRef  PubMed  CAS  Google Scholar 

  • Kim JS, Cho MJ, Song KS et al (2002) Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 54:403–408

    CrossRef  PubMed  CAS  Google Scholar 

  • Klautke G, Feyerherd P, Ludwig K et al (2005) Intensified concurrent radiochemotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer. Br J Cancer 92:1215–1220

    CrossRef  PubMed  CAS  Google Scholar 

  • Kopp R, Rothbauer E, Mueller E et al (2003) Reduced survival of rectal cancer patients with increased tumor epidermal growth factor receptor levels. Dis Colon Rectum 46:1391–1399

    CrossRef  PubMed  Google Scholar 

  • Kouloulias V, Plataniotis G, Kouvaris J et al (2005) Radiochemotherapy combined with intracavitary hyperthermia for anal cancer: feasibility and long-term results from a phase II randomized trial. Am J Clin Oncol 28:91–99

    CrossRef  PubMed  Google Scholar 

  • Krook JE, Moertel CG, Gunderson LL et al (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709–715

    CrossRef  PubMed  CAS  Google Scholar 

  • Le LH, Chetty R, Moore MJ (2005) Epidermal growth factor receptor expression in anal canal carcinoma. Am J Clin Pathol 124:20–23

    CrossRef  PubMed  CAS  Google Scholar 

  • Lee JH, Ahn JH, Bahng H et al (2002) Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report. J Clin Oncol 20:1751–1758

    CrossRef  PubMed  CAS  Google Scholar 

  • Loi S, Ngan SY, Hicks RJ et al (2005) Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial. Br J Cancer 92:655–661

    CrossRef  PubMed  CAS  Google Scholar 

  • Magne N, Fischel JL, Formento P et al (2003) Oxaliplatin-5-fluorouracil and ionizing radiation. Importance of the sequence and influence of p53 status. Oncology 64:280–287

    CrossRef  PubMed  CAS  Google Scholar 

  • Martenson JA, Lipsitz SR, Lefkopoulou M et al (1995) Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group study. Cancer 76:1731–1736

    CrossRef  PubMed  CAS  Google Scholar 

  • Mehta VK, Cho C, Ford JM et al (2003) Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 55:132–137

    CrossRef  PubMed  Google Scholar 

  • Miller EJ, Quan SH, Thaler HT (1991) Treatment of squamous cell carcinoma of the anal canal. Cancer 67:2038–2041

    CrossRef  PubMed  CAS  Google Scholar 

  • Minsky BD, Cohen AM, Kemeny N et al (1992) Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 10:79–84

    PubMed  CAS  Google Scholar 

  • Moertel CG, Childs DS Jr, Reitemeier RJ et al (1969) Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 2:865–867

    CrossRef  PubMed  CAS  Google Scholar 

  • Ngan SY, Michael M, Mackay J et al (2004) A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer. Br J Cancer 91:1019–1024

    PubMed  CAS  Google Scholar 

  • Nigro ND, Vaitkevicius VK, Considine B Jr (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17:354–356

    PubMed  CAS  Google Scholar 

  • NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. J Am Med Assoc 264:1444–1450

    CrossRef  Google Scholar 

  • O’Connell MJ, Martenson JA, Wieand HS et al (1994) Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502–507

    CrossRef  PubMed  CAS  Google Scholar 

  • Rich TA, Kirichenko AV (2001) Camptothecin schedule and timing of administration with irradiation. Oncology (Williston Park) 15:37–41

    PubMed  CAS  Google Scholar 

  • Rich TA, Ajani JA, Morrison WH et al (1993) Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother Oncol 27:209–215

    CrossRef  PubMed  CAS  Google Scholar 

  • Rödel C, Grabenbauer GG, Papadopoulos T et al (2003) Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21:3098–3104

    CrossRef  PubMed  CAS  Google Scholar 

  • Roh MS, Petrelli N, Wieand S et al (2001) Phase III randomized trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03). Proc Am Soc Clin Oncol 20:123a

    Google Scholar 

  • Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative radiochemotherapy for rectal cancer. N Engl J Med 351:1731–1740

    CrossRef  PubMed  CAS  Google Scholar 

  • Sawada N, Ishikawa T, Sekiguchi F et al (1999) X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res 5:2948–2953

    PubMed  CAS  Google Scholar 

  • Schuller J, Cassidy J, Dumont E et al (2000) Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol 45:291–297

    CrossRef  PubMed  CAS  Google Scholar 

  • Sischy B, Doggett RL, Krall JM et al (1989) Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314. J Natl Cancer Inst 81:850–856

    PubMed  CAS  Google Scholar 

  • Smalley SR, Benedetti J, Williamson S et al (2003) Intergroup 0144: phase III trial of 5-FU based chemotherapy regimens plus radiotherapy (XRT) in postoperative adjuvant rectal cancer. Bolus 5-FU vs prolonged venous infusion (PVI) before and after XRT + PVI vs bolus 5-FU + leucovorin (LV) + levamisole (LEV) before and after XRT + bolus 5-FU + LV. Proc Am Soc Clin Oncol, Abstract 1006

    Google Scholar 

  • Souglakos J, Androulakis N, Mavroudis D et al (2003) Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer. Int J Radiat Oncol Biol Phys 56:1284–1287

    CrossRef  PubMed  Google Scholar 

  • Staib L, Kornmann M, Roettinger E et al (2004) Adjuvant radiochemotherapy in resectable stage II, III rectal cancer: results of the FOGT-2 trial. Proc Am Soc Clin Oncol, Abstract 3608

    Google Scholar 

  • Tanum G, Tveit K, Karlsen KO et al (1991) Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity. Cancer 67:2462–2466

    CrossRef  PubMed  CAS  Google Scholar 

  • Tepper JE, O’Connell M, Niedzwiecki D et al (2002) Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control-final report of intergroup 0114. J Clin Oncol 20:1744–1750

    CrossRef  PubMed  CAS  Google Scholar 

  • Tveit KM, Guldvog I, Hagen S et al (1997) Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 84:1130–1135

    CrossRef  PubMed  CAS  Google Scholar 

  • Twelves C, Wong A, Nowacki MP et al (2005) Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 352:2696–2704

    CrossRef  PubMed  CAS  Google Scholar 

  • UKCCCR Anal Cancer Trial Working Party. (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348:1049–1054

    CrossRef  Google Scholar 

  • Van Cutsem E, Hoff PM, Harper P et al (2004) Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br J Cancer 90:1190–1197

    CrossRef  PubMed  CAS  Google Scholar 

  • Voelter V, Stupp R, Matter M et al (2003) Preoperative hyperfractionated accelerated radiotherapy (HART) and concomitant CPT-11 in locally advanced rectal carcinoma: a phase I study. Int J Radiat Oncol Biol Phys 56:1288–1294

    CrossRef  PubMed  Google Scholar 

  • Willett CG, Chung D, Sahani D et al (2004a) Phase I study of neoadjuvant bevacizumab, 5-fluorouracil, and radiation therapy followed by surgery for patients with primary rectal cancer. Proc Am Soc Clin Oncol, Abstract 3589

    Google Scholar 

  • Willett CG, Boucher Y, di Tomaso E et al (2004b) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10:145–147

    CrossRef  PubMed  CAS  Google Scholar 

  • Wolmark N, Wieand HS, Hyams DM et al (2000) Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 92:388–396

    CrossRef  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik and Poliklinik für Strahlentherapie, Universitätsklinikum Erlangen, Postfach 2306, Universitätsstrasse 27, 91054, Erlangen, Germany

    Claus Rödel MD

  2. Universitätsklinikum Erlangen, Postfach 2306, Universitätsstrasse 27, 91054, Erlangen, Germany

    Rolf Sauer MD (Professor, Direktor der Strahlenklinik)

Authors
  1. Claus Rödel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rolf Sauer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford School of Medicine, 269 Campus Drive Center for Clinical Science and Research, Rm 1255, Stanford, CA, 94305-5152, USA

    J. Martin Brown PhD

  2. Department of Human Oncology, University of Wisconsin Hospital Medical School, 600 Highland Ave., K4 312-3684, Madison, WI, 53792, USA

    Minesh P. Mehta MD

  3. Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Strasse 22, 81675, München, Germany

    Carsten Nieder MD

Rights and permissions

Reprints and Permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Rödel, C., Sauer, R. (2006). Applications in Rectal and Anal Cancer. In: Brown, J.M., Mehta, M.P., Nieder, C. (eds) Multimodal Concepts for Integration of Cytotoxic Drugs. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-35662-2_18

Download citation

  • DOI: https://doi.org/10.1007/3-540-35662-2_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25655-7

  • Online ISBN: 978-3-540-35662-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation